Biofilms in Orthopaedic Infections

Biofilms in Orthopaedic Infections

Biofilms in Orthopaedic Infections

On this page

Biofilm Basics - Slimy Strongholds

  • Definition: Structured microbial communities encased in a self-produced Extracellular Polymeric Substance (EPS).
  • EPS Matrix: Primarily polysaccharides, proteins, extracellular DNA (eDNA), and lipids. Acts as a protective barrier.
  • Key Features:
    • Adherence: To implants (metal, polymer) & host tissues.
    • Protection: Shields bacteria from host immune cells (phagocytes) & antibiotics.
    • Resistance: Can exhibit ↑ 100-1000x antibiotic tolerance vs. planktonic forms.
    • Communication: Quorum sensing coordinates biofilm behavior.
  • Orthopaedic Significance: Critical in prosthetic joint infections (PJI), fracture-related infections (FRI), and chronic osteomyelitis. Scanning electron micrograph of biofilm

⭐ Biofilms contain "persister cells," dormant variants highly tolerant to antibiotics, contributing to infection recurrence after treatment cessation and implant retention attempts.

Biofilm Formation - The Attachment Story

  • Attachment (Steps 1-3 in flowchart):
    • Initial: Planktonic cells, reversible (Van der Waals forces).
    • Irreversible: Adhesins (e.g., MSCRAMMs), pili; aided by host conditioning film (e.g., fibronectin).
  • Development (Steps 4-5):
    • Microcolonies: Bacterial aggregation, EPS (Exopolysaccharide) matrix production.
    • Maturation: Complex 3D structure, intercellular communication via quorum sensing.
  • Dispersal (Step 6):
    • Enzymatic degradation of EPS matrix, release of planktonic bacteria.

Biofilm formation stages and antibiotic resistance

⭐ Key adhesins for Staphylococcus aureus include MSCRAMMs (e.g., FnBPA/B binding fibronectin), crucial for initial attachment to implant surfaces conditioned by host proteins.

Biofilm Pathogenesis - Resistance & Evasion

  • Physical Barrier: Extracellular Polymeric Substance (EPS) matrix.
    • Limits antibiotic penetration (diffusion barrier).
    • Shields from host immune cells (phagocytes, antibodies).
  • Altered Microenvironment:
    • Slow bacterial growth rate (↓ metabolic activity) → ↓ antibiotic efficacy.
    • Nutrient/oxygen gradients → dormant persister cells.
    • Acidic pH, ↑ $CO_2$, ↓ $O_2$.
  • Persister Cells:
    • Metabolically dormant, highly antibiotic-tolerant (not resistant).
    • Can repopulate biofilm after antibiotic course.
  • Resistance Mechanisms:
    • Concentration of antibiotic-degrading enzymes (e.g., β-lactamases) in EPS.
    • Upregulation of efflux pumps.
    • Horizontal gene transfer (HGT) of resistance genes facilitated by close proximity.
  • Immune Evasion:
    • EPS hides bacterial PAMPs (Pathogen-Associated Molecular Patterns).
    • Inhibits phagocytosis & complement activation.
    • Quorum sensing coordinates defense mechanisms.

Bacterial antibiotic resistance mechanisms

⭐ Biofilms can exhibit 10-1000 times more resistance to antimicrobial agents compared to their planktonic (free-floating) counterparts. This is a key reason for chronic and recurrent orthopaedic infections.

Biofilm Management - Diagnosis & Attack

Diagnosis:

  • Clinical: Chronic, low-grade, implant-associated.
  • Microbiology:
    • Sonication of explants ↑yield.
    • Prolonged culture (up to 14 days).
    • Molecular methods (16S rRNA PCR).
  • Imaging: X-ray, MRI; PET-CT (metabolic activity).
  • Biomarkers: Synovial α-defensin, leukocyte esterase.

Attack Strategies:

  • Surgical: Cornerstone. Aggressive debridement of infected tissue.
  • Implant strategy: DAIR (early <4 wks, stable implant), 1/2-stage exchange (chronic).
  • Antimicrobial Therapy:
    • Biofilm-active agents (Rifampicin, Daptomycin).
    • Combination therapy essential.
    • Prolonged duration (4-6 wks IV, then oral).
    • High local delivery (antibiotic spacers).
  • Novel (adjunctive): QS inhibitors, phage therapy.

Biofilm formation and antibiotic resistance

⭐ Rifampicin is highly effective against staphylococcal biofilms but must ALWAYS be used in combination (e.g., with a fluoroquinolone or fusidic acid) to prevent rapid emergence of resistance.

High‑Yield Points - ⚡ Biggest Takeaways

  • Biofilms: Structured bacterial communities in self-produced EPS matrix, adhering to implants & devitalized tissue.
  • Central to chronic orthopaedic infections like PJI & implant-associated osteomyelitis.
  • Exhibit ↑ antibiotic resistance due to EPS barrier & altered bacterial metabolic states.
  • Diagnosis: Sonication of explanted hardware or multiple intraoperative tissue cultures.
  • Treatment: Thorough surgical debridement, implant removal/exchange, plus prolonged systemic antibiotics.
  • Quorum sensing regulates biofilm formation, offering novel therapeutic targets.

Practice Questions: Biofilms in Orthopaedic Infections

Test your understanding with these related questions

A patient develops an infection of methicillin resistant Staphylococcus aureus. All of the following can be used to treat this infection except

1 of 5

Flashcards: Biofilms in Orthopaedic Infections

1/10

What is the most common complication of chronic osteomyelitis?_____

TAP TO REVEAL ANSWER

What is the most common complication of chronic osteomyelitis?_____

Pathological fracture

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial